Dr. Sean Patrick Dineen, MD

Dr. Dineen practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Dineen's NPI, 1083737332, was assigned on April 9, 2007. Dr. Dineen graduated from University Of Louisville School Of Medicine in 2003. Dr. Dineen's Kentucky license number on file is 48175.

Dr. Dineen's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Dineen's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Dineen is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Dineen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dineen practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Dineen's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Dineen is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Dineen's licenses on file in 3 states: Kentucky, Florida and Texas.

Dmand AI lists colon removal among the conditions Dr. Dineen treats.

CMS data shows 145 Medicare services from Dr. Dineen across 3 procedure codes in 2024, for 69 Medicare patients. Medicare paid $9,668 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Dineen in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have cancer, and 72% have high blood pressure. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dineen's median patient age at 64, with 59% women.

In 2021, Dr. Dineen wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $41 in total drug cost. In 2017, CMS named 59 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Dineen for performance year 2024, reported as part of a group. Dr. Dineen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dineen as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 97 papers to Dr. Dineen, published from 2003 to 2025. 2020 was the busiest year, with 14. The most frequent topics are Cytoreduction Surgical Procedures, Peritoneal Neoplasms and Antineoplastic Combined Chemotherapy Protocols. Dr. Dineen has published most often in Ann Surg Oncol. Dr. Dineen's most frequent co-authors are Keith Francis Fournier, MD, Jordan M. Cloyd, MD and Travis Edward Grotz, MD.

Dmand AI links Dr. Dineen to 1 clinical trial. Conditions studied include Infections.

CMS Open Payments shows 20 general payments to Dr. Dineen from 4 drug and device companies from 2019 to 2025. Education make up the largest share, 56% of the total. Intuitive Surgical, Inc. paid the most, $3,845.

Dmand AI lists 21 awards for Dr. Dineen, most recently Medical Student Teaching Honors in 2020.

Dr. Dineen graduated from University Of Louisville School Of Medicine in 2003. Dr. Dineen is a member of AHPBA Clinical Trials Subcommittee, ACS, Association of Academic Surgeons, Florida Chapter of the American College of Surgeons Education Committee, Society for Surgery of the Alimentary Tract and Society for Surgery of the Alimentary Tract (SSAT) Postgraduate Education Committee.

Dr. Dineen is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.